Table 3.
Incremental cost per event prevented of treating patients at a range of pretreatment risks of a coronary event over five years
| 
Pretreatment coronary risk over 5 years | 
|||||||
|---|---|---|---|---|---|---|---|
| Treatment | 5% | 7.5% | 10% | 15% | 20% | 25% | 30% | 
|  Aspirin 75 mg + follow up  | 
 £7 900  | 
 £4 900  | 
 £3 500  | 
 £2 200  | 
 £1 600  | 
 £1 300  | 
 £1 100  | 
|  Bendrofluazide 2.5 mg + atenolol 50 mg  | 
 £24 000  | 
 £16 000  | 
 £12 000  | 
 £8 000  | 
 £6 000  | 
 £4 800  | 
 £4 000  | 
|  Enalapril 20 mg  | 
 £67 800  | 
 £45 200  | 
 £33 900  | 
 £22 600  | 
 £16 900  | 
 £13 600  | 
 £11 300  | 
|  Simvastatin 40 mg  | 
 £244 800  | 
 £163 200  | 
 £122 400  | 
 £81 600  | 
 £61 200  | 
 £49 000  | 
 £40 800  | 
| Clopidogrel 75 mg | £1 054 400 | £702 900 | £527 200 | £351 500 | £263 600 | £210 900 | £175 700 |